FDA Approves New Treatments for Bladder Cancer
The FDA has approved INLEXZO™, a new intravesical system for treating certain bladder cancers, offering a bladder-preserving option for patients unresponsive to BCG therapy, with promising clinical trial results showing high response rates and manageable safety profile.